MedPath

University of Virginia

University of Virginia logo
🇺🇸United States
Ownership
Private
Established
1819-01-01
Employees
10K
Market Cap
-
Website
http://www.virginia.edu

Voice Outcomes Following Thyroidectomy

Conditions
Thyroid Cancer
Thyroid Nodule
First Posted Date
2018-09-05
Last Posted Date
2022-05-09
Lead Sponsor
University of Virginia
Target Recruit Count
45
Registration Number
NCT03657654
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension)

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
First Posted Date
2018-07-19
Last Posted Date
2022-08-31
Lead Sponsor
University of Virginia
Target Recruit Count
164
Registration Number
NCT03591354
Locations
🇺🇸

University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States

🇺🇸

Harvard University (Joslin Diabetes Center), Boston, Massachusetts, United States

🇺🇸

Sansum Diabetes Research Institute, Santa Barbara, California, United States

and more 4 locations

Prospective Comparison of Metolazone Versus Chlorothiazide for Acute Decompensated Heart Failure With Diuretic Resistance

Phase 4
Terminated
Conditions
Heart Failure Acute
Heart Failure
Heart Failure With Reduced Ejection Fraction
Cardiovascular Diseases
Interventions
First Posted Date
2018-07-02
Last Posted Date
2021-02-16
Lead Sponsor
University of Virginia
Target Recruit Count
5
Registration Number
NCT03574857
Locations
🇺🇸

University of Virginia Health System, Charlottesville, Virginia, United States

Immune Effects in Patients Treated With Whole Breast Irradiation

Not Applicable
Conditions
Breast Cancer
Interventions
Diagnostic Test: Blood Draw
First Posted Date
2018-06-25
Last Posted Date
2018-06-25
Lead Sponsor
University of Virginia
Target Recruit Count
50
Registration Number
NCT03567044
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Device: Sensor-augmented pump (SAP)
First Posted Date
2018-06-20
Last Posted Date
2020-04-28
Lead Sponsor
University of Virginia
Target Recruit Count
168
Registration Number
NCT03563313
Locations
🇺🇸

Sansum Diabetes Research Institute, Santa Barbara, California, United States

🇺🇸

Stanford University, Stanford, California, United States

🇺🇸

Barbara Davis Center, University of Colorado, Aurora, Colorado, United States

and more 4 locations

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Completed
Conditions
Tuberculosis
First Posted Date
2018-06-18
Last Posted Date
2022-03-09
Lead Sponsor
University of Virginia
Target Recruit Count
478
Registration Number
NCT03559582

HPV DNA Testing Through Mobile Mammography Unit

Not Applicable
Completed
Conditions
Cervical Cancer
Interventions
Device: HPV self collection
First Posted Date
2018-06-11
Last Posted Date
2024-11-04
Lead Sponsor
University of Virginia
Target Recruit Count
33
Registration Number
NCT03551028
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

Glucagon Counterregulation in Type 1 Diabetes

Not Applicable
Terminated
Conditions
Type 1 Diabetes Mellitus
Interventions
Other: Basal pramlintide and reduced basal insulin
Other: Basal insulin alone
Other: CGM
Other: Acetaminophen test
Other: Insulin-induced hypoglycemia
Other: Exercise-induced hypoglycemia
First Posted Date
2018-06-06
Last Posted Date
2022-03-28
Lead Sponsor
University of Virginia
Target Recruit Count
13
Registration Number
NCT03547427
Locations
🇺🇸

University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States

Oral Propanolol for Surgically Inaccessible Cavernous Malformations

Phase 1
Conditions
Cavernous Malformations,Cerebral and/or Spinal
Interventions
Drug: Placebo Oral Tablet
First Posted Date
2018-05-14
Last Posted Date
2018-05-14
Lead Sponsor
University of Virginia
Target Recruit Count
346
Registration Number
NCT03523650
Locations
🇺🇸

Univeristy of Virginia, Charlottesville, Virginia, United States

Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

Early Phase 1
Completed
Conditions
Vascular Stiffness
Insulin Sensitivity
Interventions
Drug: Dextrose 20% solution
First Posted Date
2018-05-09
Last Posted Date
2022-05-13
Lead Sponsor
University of Virginia
Target Recruit Count
15
Registration Number
NCT03520569
Locations
🇺🇸

University of Virginia, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath